Overall rank by patents
#24,797
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F23N (REGULATING OR CONTROLLING COMBUSTION).
The verdict
Maxitrol holds 11 US patents across 7 technology areas, rank #24,797 of 50,000 tracked assignees.
Maxitrol Company has been granted 11 US utility patents between 2015 and 2025, placing Maxitrol Company at rank #24,797 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in F23N (REGULATING OR CONTROLLING COMBUSTION). As a US Corporation, Maxitrol Company is one of the more focused assignees in the PatentsView dataset. By volume, Maxitrol sits between Mavagail Technology, Llc (11 patents, rank #24,793) and Medtronic Corevalve Llc (11 patents, rank #24,801) - the closest US assignees by grant volume. The composite Innovation Score of 35.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Maxitrol Company's 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Maxitrol Company against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mavagail Technology, LLC
11 patents
Maverick Industries, Inc.
11 patents
Max Delbrück-Centrum Für Molekulare Medizin
11 patents
Maxion Wheels Germany Holding GmbH
11 patents
Med-Genesis, LLC
11 patents
Medical Specialties, Inc.
11 patents
Medovex Corp.
11 patents
Medtronic CoreValve LLC
11 patents
Maxitrol Company
11 patents
What this shows Maxitrol holds 11 patents at rank #24,797, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,797 in granted patent volume.
Other assignees with the most granted patents in Maxitrol's primary technology class.
Maxitrol's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 49% higher than 51% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 9.1% |
| 2016 | 1 | 9.1% |
| 2017 | 1 | 9.1% |
| 2019 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
| 2022 | 3 | 27.3% |
| 2024 | 1 | 9.1% |
| 2025 | 1 | 9.1% |
Top 7 of 7 technology areas
Overall rank by patents
#24,797
Across all tracked assignees
35.6 out of 100
How to use this portfolio
Maxitrol's 11 grants land it in the top 49% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.